Variant report
Variant | esv2762801 |
---|---|
Chromosome Location | chr9:17029570-17054625 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:17033642-17033959 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr9:17033518-17033953 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr9:17031555-17031833 | HepG2 | liver: | n/a | chr9:17031696-17031707 |
4 | CTCF | chr9:17054020-17054170 | AoAF | blood vessel: | n/a | n/a |
5 | CTCF | chr9:17054020-17054170 | Hela-S3 | cervix: | n/a | n/a |
6 | CTCF | chr9:17054000-17054150 | HBMEC | blood vessel: | n/a | n/a |
7 | CTCF | chr9:17054080-17054230 | RPTEC | kidney: | n/a | n/a |
8 | CTCF | chr9:17054020-17054170 | HEK293 | kidney: | n/a | n/a |
9 | CTCF | chr9:17054060-17054210 | GM12869 | blood: | n/a | n/a |
10 | CTCF | chr9:17053960-17054110 | HA-sp | spinal cord: | n/a | n/a |
11 | CTCF | chr9:17042500-17042650 | A549 | lung: | n/a | n/a |
12 | CTCF | chr9:17042571-17042684 | A549 | lung: | n/a | n/a |
13 | CTCF | chr9:17054100-17054250 | Hela-S3 | cervix: | n/a | n/a |
14 | CTCF | chr9:17053920-17054070 | HEK293 | kidney: | n/a | n/a |
15 | CTCF | chr9:17042568-17042699 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | CTCF | chr9:17051269-17051282 | GM10248 | blood: | n/a | n/a |
17 | CTCF | chr9:17054100-17054250 | BJ | skin: | n/a | n/a |
18 | CTCF | chr9:17052922-17053001 | Fibrobl | skin: | n/a | n/a |
19 | CTCF | chr9:17054060-17054210 | HMF | breast: | n/a | n/a |
20 | CTCF | chr9:17053960-17054110 | HPAF | blood vessel: | n/a | n/a |
21 | CTCF | chr9:17054080-17054230 | A549 | lung: | n/a | n/a |
22 | CTCF | chr9:17051020-17051170 | AoAF | blood vessel: | n/a | n/a |
23 | CTCF | chr9:17042593-17042631 | HepG2 | liver: | n/a | n/a |
24 | CTCF | chr9:17053980-17054130 | SK-N-SH_RA | brain: | n/a | n/a |
25 | E2F4 | chr9:17049749-17049949 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | EP300 | chr9:17028974-17029757 | SK-N-SH | brain: | n/a | n/a |
27 | GATA3 | chr9:17029159-17029606 | SH-SY5Y | brain: | n/a | n/a |
28 | MAX | chr9:17044191-17044482 | H1-hESC | embryonic stem cell: | n/a | chr9:17044314-17044324 |
29 | MAX | chr9:17052631-17052985 | H1-hESC | embryonic stem cell: | n/a | chr9:17052812-17052821 |
30 | MAX | chr9:17044263-17044477 | NB4 | blood: | n/a | chr9:17044314-17044324 |
31 | POLR2A | chr9:17032252-17032301 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr9:17030740-17030757 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr9:17043643-17043741 | MCF-7 | breast: | n/a | n/a |
34 | POLR2A | chr9:17053802-17053806 | HepG2 | liver: | n/a | n/a |
35 | POLR2A | chr9:17053600-17053793 | HepG2 | liver: | n/a | n/a |
36 | POLR2A | chr9:17039275-17039428 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr9:17044658-17044704 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr9:17030986-17031163 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | POLR2A | chr9:17053128-17053328 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | RAD21 | chr9:17042413-17042826 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | RXRA | chr9:17030974-17031174 | HepG2 | liver: | n/a | n/a |
42 | SMC3 | chr9:17033864-17033906 | Hela-S3 | cervix: | n/a | n/a |
43 | SRF | chr9:17040687-17040915 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | STAT3 | chr9:17045674-17045680 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | STAT3 | chr9:17033953-17034118 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | STAT3 | chr9:17041272-17041398 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | ZBTB33 | chr9:17030958-17031187 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CNTLN-4 | chr9:17053899-17054200 | NONHSAT130298 |
2 | lnc-CNTLN-1 | chr9:17048917-17049039 | ENSG00000237153.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL720P | TF binding region |
ENSG00000237153 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184493867 | chr9:17037401-17037402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186926844 | chr9:17037402-17037403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566328765 | chr9:17037407-17037408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565965133 | chr9:17037431-17037432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113396386 | chr9:17037446-17037447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138358142 | chr9:17037449-17037450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554662360 | chr9:17037473-17037474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184227762 | chr9:17037585-17037586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537392427 | chr9:17037603-17037604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558957897 | chr9:17037675-17037676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149561625 | chr9:17037692-17037693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545356140 | chr9:17037698-17037699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560460466 | chr9:17037701-17037702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144248465 | chr9:17037702-17037703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372511613 | chr9:17037730-17037731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547943406 | chr9:17037751-17037752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533806856 | chr9:17037765-17037766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376173101 | chr9:17037771-17037772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201976966 | chr9:17037775-17037776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372762602 | chr9:17037776-17037777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34898115 | chr9:17037788-17037789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560827641 | chr9:17037806-17037807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148686156 | chr9:17037810-17037811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113941193 | chr9:17037825-17037826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142227973 | chr9:17037831-17037832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147397632 | chr9:17037849-17037850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547709638 | chr9:17037857-17037858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371460604 | chr9:17037886-17037887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576598288 | chr9:17037907-17037908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139669559 | chr9:17037913-17037914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs193012456 | chr9:17037919-17037920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536460927 | chr9:17038018-17038019 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145088993 | chr9:17038035-17038036 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80172077 | chr9:17038127-17038128 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185640969 | chr9:17038134-17038135 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537593779 | chr9:17038145-17038146 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190516562 | chr9:17038154-17038155 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543942390 | chr9:17038160-17038161 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs180790962 | chr9:17038167-17038168 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12005194 | chr9:17038175-17038176 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554123716 | chr9:17038213-17038214 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147586388 | chr9:17038220-17038221 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185389265 | chr9:17038222-17038223 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188539677 | chr9:17038251-17038252 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531395290 | chr9:17038262-17038263 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537980403 | chr9:17038276-17038277 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181306096 | chr9:17038281-17038282 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564804971 | chr9:17038304-17038305 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35019805 | chr9:17038307-17038308 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531997198 | chr9:17038341-17038342 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17037400-17038000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr9:17037600-17039200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:17038000-17038400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr9:17038000-17038400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:17039200-17039600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr9:17039200-17040000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr9:17042200-17043000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr9:17043000-17044800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr9:17044800-17045600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr9:17052800-17053200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr9:17053200-17062600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |